Every round on record, with the sources behind each and the investors on them.
MiRus develops innovative medical solutions using proprietary alloys for safer and more durable implants in cardiovascular and orthopedic applications.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source describes an investment rather than assigning a financing-stage label. The 34% equity stake is not stated as a valuation.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.5B | 2026-05-18 | not stated | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source describes an investment rather than assigning a financing-stage label. The 34% equity stake is not stated as a valuation. | ||||